Monika Roy

Monika Roy

Auto-generated profile, based on publicly available information

Monika Roy

Affiliation University of California, San Francisco, San Fancisco, California, United States of America

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2019 in Current HIV/AIDS Reports
Verified
Journal Article
Closed access
PDF file
MRMonika Roy
Monika Roy
CMCarolyn Bolton Moore
Carolyn Bolton Moore
ISIzukanji Sikazwe
Izukanji Sikazwe
CHCharles B. Holmes
Charles B. Holmes

17 May 2016 in Current HIV/AIDS Reports
Verified
Journal Article
Closed access
PDF file
MRMonika Roy
Monika Roy
NCNancy Czaicki
Nancy Czaicki
CHCharles Holmes
Charles Holmes
SCSaurabh Chavan
Saurabh Chavan
ATApollo Tsitsi
Apollo Tsitsi
EGElvin Geng
Elvin Geng

1 June 2013 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
RFRobyn Neblett Fanfair
Robyn Neblett Fanfair
OHOrville Heslop
Orville Heslop
KEKizee Etienne
Kizee Etienne
LRLois Rainford
Lois Rainford
MRMonika Roy
Monika Roy
BPBenjamin J. Park
Benjamin J. Park
We investigated an increase in Trichosporon asahii isolates among inpatients. We identified 63 cases; 4 involved disseminated disease. Trichosporon species was recovered from equipment cleaning rooms, washbasins, and fomites, which suggests transmission through washbasins. Patient washbasins should be single-patient use only; adherence to appropriate hospital disinfection guidelines was recommended.

1 July 2020 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
MRMonika Roy
Monika Roy
CBCarolyn Bolton-Moore
Carolyn Bolton-Moore
ISIzukanji Sikazwe
Izukanji Sikazwe
MMMpande Mukumbwa-Mwenechanya
Mpande Mukumbwa-Mwenechanya
EEEmilie Efronson
Emilie Efronson
CHCharles B. Holmes
Charles B. Holmes
Current models of HIV service delivery, with frequent facility visits, have led to facility congestion, patient and healthcare provider dissatisfaction, and suboptimal quality of services and retention in care. The Zambian urban adherence club (AC) is a health service innovation designed to improve on-time drug pickup and retention in HIV care through off-hours facility access and pharmacist-led group drug distribution. Similar models of differentiated service delivery (DSD) have shown promise in South Africa, but observational analyses of these models are prone to bias and confounding. We sought to evaluate the effectiveness and implementation of ACs in Zambia using a more rigorous study design. Using a matched-pair cluster randomized study design (ClinicalTrials.gov: NCT02776254), 10 clinics were randomized to intervention (5 clinics) or control (5 clinics). At each clinic, between May 19 and October 27, 2016, a systematic random sample was assessed for eligibility (HIV+, age ≥ 14 years, on ART >6 months, not acutely ill, CD4 count not 7 days late). Intervention effect was estimated using unadjusted Kaplan–Meier survival curves and a Cox proportional hazards model to derive an adjusted hazard ratio (aHR). Medication possession ratio (MPR) and implementation outcomes (adoption, acceptability, appropriateness, feasibility, and fidelity) were additionally evaluated as secondary outcomes. Baseline characteristics were similar between 571 intervention and 489 control participants with respect to median age (42 versus 41 years), sex (62% versus 66% female), median time since ART initiation (4.8 versus 5.0 years), median CD4 count at study enrollment (506 versus 533 cells/mm3), and baseline retention (53% versus 55% with at least 1 late drug pickup in previous 12 months). The rate of late drug pickup was lower in intervention participants compared to control participants (aHR 0.26, 95% CI 0.15–0.45, p < 0.001). Median MPR was 100% in intervention participants compared to 96% in control participants (p < 0.001). Although 18% (683/3,734) of AC group meeting visits were missed, on-time drug pickup (within 7 days) still occurred in 51% (350/683) of these missed visits through alternate means (use of buddy pickup or early return to the facility). Qualitative evaluation suggests that the intervention was acceptable to both patients and providers. While patients embraced the convenience and patient-centeredness of the model, preference for traditional adherence counseling and need for greater human resources influenced intervention appropriateness and feasibility from the provider perspective. The main limitations of this study were the small number of clusters, lack of viral load data, and relatively short follow-up period. ACs were found to be an effective model of service delivery for reducing late ART drug pickup among HIV-infected adults in Zambia. Drug pickup outside of group meetings was relatively common and underscores the need for DSD models to be flexible and patient-centered if they are to be effective. ClinicalTrials.gov NCT02776254.

15 August 2016 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
MRMonika Roy
Monika Roy
WMWinnie MBchB Muyindike
Winnie MBchB Muyindike
TVTara Vijayan
Tara Vijayan
MKMichael Bs Kanyesigye
Michael Bs Kanyesigye
MBMwebesa MBchB Bwana
Mwebesa MBchB Bwana
EGElvin Geng
Elvin Geng
Background: The uptake of intensified active TB case-finding among HIV-infected patients using symptom screening is not well understood. We evaluated the rate and completeness of each interim step in the TB pulmonary “diagnostic cascade” to understand real-world barriers to active TB case detection. Methods: We conducted a cohort analysis of new, antiretroviral therapy–naive, HIV-infected patients who attended a large HIV clinic in Mbarara, Uganda (March 1, 2012—September 30, 2013). We used medical records to extract date of completion of each step in the diagnostic cascade: symptom screen, order, collection, processing, and result. Factors associated with lack of sputum order were evaluated using multivariate Poisson regression and chart review of 50 screen-positive patients. Results: Of 2613 patients, 2439 (93%) were screened for TB and 682 (28%) screened positive. Only 90 (13.2%) had a sputum order. Of this group, 83% completed the diagnostic cascade, 13% were diagnosed with TB, and 50% had a sputum result within 1 day of their visit. Sputum ordering was associated with WHO stage 3 or 4 HIV disease and greater number of symptoms. The main identifiable reasons for lack of sputum order in chart review were treatment of presumed malaria (51%) or bacterial infection (43%). Conclusions: The majority of newly enrolled HIV-infected patients who screened positive for suspected TB did not have a sputum order, and those who did were more likely to have more symptoms and advanced HIV disease. Further evaluation of provider behavior in the management of screen-positive patients could improve active TB case detection rates.

28 September 2018 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
MRMonika Roy
Monika Roy
CHCharles Holmes
Charles Holmes
ISIzukanji Sikazwe
Izukanji Sikazwe
TSThea Savory
Thea Savory
MMMwanza Wa Mwanza
Mwanza Wa Mwanza
EGElvin Geng
Elvin Geng
Differentiated service delivery (DSD) for human immunodeficiency virus (HIV)–infected persons who are clinically stable on antiretroviral therapy (ART) has been embraced as a solution to decrease access barriers and improve quality of care. However, successful DSD implementation is dependent on understanding the prevalence, incidence, and durability of clinical stability. We evaluated visit data in a cohort of HIV-infected adults who made at least 1 visit between 1 March 2013 and 28 February 2015 at 56 clinics in Zambia. We described visit frequency and appointment intervals using conventional stability criteria and used a mixed-effects linear regression model to identify predictors of appointment interval. We developed a multistate model to characterize patient stability over time and calculated incidence rates for transition between states. Overall, 167819 patients made 3418018 post–ART initiation visits between 2004 and 2015. Fifty-four percent of visits were pharmacy refill-only visits, and 24% occurred among patients on ART for >6 months and whose current CD4 was >500 cells/mm3. Median appointment interval at clinician visits was 59 days, and time on ART and current CD4 were not strong predictors of appointment interval. Cumulative incidence of clinical stability was 66.2% at 2 years after enrollment, but transition to instability (31 events per 100 person-years) and lapses in care (41 events per100 person-years) were common. Current facility-based care was characterized by high visit burden due to pharmacy refills and among treatment-experienced patients. Differentiated service delivery models targeted toward stable patients need to be adaptive given that clinical stability was highly transient and lapses in care were common.